{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:38Z","timestamp":1794020018792,"version":"4.8.0"},"reference-count":46,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2025.0185","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:52:58Z","timestamp":1765781578000},"source":"Crossref","is-referenced-by-count":4,"title":["Moyamoya disease: Pathophysiology, diagnosis, and treatment"],"prefix":"10.3238","author":[{"given":"Robert","family":"Mertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Nikolaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Danyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vajkoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"10.3238\/arztebl.m2025.0185_ref1","unstructured":"Takeuchi K, Shimizu K: [Hypoplasia of the bilateral internal carotid arteries]. Brain Nerve (Tokyo) 1957; 9: 37–43."},{"key":"10.3238\/arztebl.m2025.0185_ref2","doi-asserted-by":"crossref","unstructured":"Scott RM, Smith ER: Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360: 1226–37.","DOI":"10.1056\/NEJMra0804622"},{"key":"10.3238\/arztebl.m2025.0185_ref3","doi-asserted-by":"crossref","unstructured":"Kr\u00e4mer M, Vajkoczy P, Khan N: Update zu Diagnostik und Therapie der Moyamoya-Angiopathie. DGNeurologie 2023; 6: 236–51.","DOI":"10.1007\/s42451-023-00559-7"},{"key":"10.3238\/arztebl.m2025.0185_ref4","doi-asserted-by":"crossref","unstructured":"Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P: Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. Eur J Neurol 2015; 22: 1012–7.","DOI":"10.1111\/ene.12702"},{"key":"10.3238\/arztebl.m2025.0185_ref5","doi-asserted-by":"crossref","unstructured":"Acker G, Goerdes S, Schmiedek P, Czabanka M, Vajkoczy P: Characterization of clinical and radiological features of quasi-moyamoya disease among European caucasians including surgical treatment and outcome. Cerebrovasc Dis 2016; 42: 464–75.","DOI":"10.1159\/000448812"},{"key":"10.3238\/arztebl.m2025.0185_ref6","doi-asserted-by":"crossref","unstructured":"Roach ES, Golomb MR, Adams R, et al.: Management of stroke in infants and children: A scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39: 2644–91.","DOI":"10.1161\/STROKEAHA.108.189696"},{"key":"10.3238\/arztebl.m2025.0185_ref7","doi-asserted-by":"crossref","unstructured":"Adil MM, Qureshi AI, Beslow LA, Jordan LC: Transient ischemic attack requiring hospitalization of children in the United States: Kids’ inpatient database 2003 to 2009. Stroke 2014; 45: 887–8.","DOI":"10.1161\/str.45.suppl_1.wmp113"},{"key":"10.3238\/arztebl.m2025.0185_ref8","doi-asserted-by":"crossref","unstructured":"Olivieri M: Schlaganf\u00e4lle im Kindesalter. Kinder- und Jugendmedizin 2019; 19: 22.","DOI":"10.1055\/s-0039-1684078"},{"key":"10.3238\/arztebl.m2025.0185_ref9","unstructured":"Horn P, Vajkoczy P, Schmiedek P: Diagnostik und Therapie der Moyamoya-Erkrankung. Dt \u00c4rztebl 2001; 98: A 1190–95 [Heft 18]."},{"key":"10.3238\/arztebl.m2025.0185_ref10","doi-asserted-by":"crossref","unstructured":"Tokairin K, Hamauchi S, Ito M, et al.: Vascular smooth muscle cell derived from IPS cell of moyamoya disease—comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovasc Dis 2020; 29: 105305.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305"},{"key":"10.3238\/arztebl.m2025.0185_ref11","doi-asserted-by":"crossref","unstructured":"Blecharz-Lang KG, Prinz V, Burek M, et al.: Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in moyamoya disease. J Cereb Blood Flow Metab 2018; 38: 1940–53.","DOI":"10.1177\/0271678X18768443"},{"key":"10.3238\/arztebl.m2025.0185_ref12","doi-asserted-by":"crossref","unstructured":"Blecharz KG, Frey D, Schenkel T, et al.: Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in moyamoya disease. J Cereb Blood Flow Metab 2017; 37: 1527–39.","DOI":"10.1177\/0271678X16658301"},{"key":"10.3238\/arztebl.m2025.0185_ref13","doi-asserted-by":"crossref","unstructured":"Mertens R, Graupera M, Gerhardt H, et al.: The genetic basis of moyamoya disease. Transl Stroke Res 2022; 13: 25–45.","DOI":"10.1007\/s12975-021-00940-2"},{"key":"10.3238\/arztebl.m2025.0185_ref14","doi-asserted-by":"crossref","unstructured":"Ihara M, Yamamoto Y, Hattori Y, et al.: Moyamoya disease: Diagnosis and interventions. Lancet Neurol 2022; 21: 747–58.","DOI":"10.1016\/S1474-4422(22)00165-X"},{"key":"10.3238\/arztebl.m2025.0185_ref15","doi-asserted-by":"crossref","unstructured":"Otten EG, Werner E, Crespillo-Casado A, et al.: Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection. Nature 2021; 594: 111–6.","DOI":"10.1038\/s41586-021-03566-4"},{"key":"10.3238\/arztebl.m2025.0185_ref16","doi-asserted-by":"crossref","unstructured":"Sonobe S, Fujimura M, Niizuma K, et al.: Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: A susceptibility gene for moyamoya disease. Brain Res 2014; 1552: 64–71.","DOI":"10.1016\/j.brainres.2014.01.011"},{"key":"10.3238\/arztebl.m2025.0185_ref17","doi-asserted-by":"crossref","unstructured":"Bersano A, Guey S, Bedini G, et al.: Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovasc Dis 2016; 41: 105–18.","DOI":"10.1159\/000442298"},{"key":"10.3238\/arztebl.m2025.0185_ref18","doi-asserted-by":"crossref","unstructured":"Bedini G, Blecharz KG, Nava S, et al.: Vasculogenic and angiogenic pathways in moyamoya disease. Curr Med Chem 2016; 23: 315–45.","DOI":"10.2174\/092986732304160204181543"},{"key":"10.3238\/arztebl.m2025.0185_ref19","doi-asserted-by":"crossref","unstructured":"Kuroda S, Fujimura M, Takahashi J, et al.: Diagnostic criteria for moyamoya disease—2021 revised version. Neurol Med Chir (Tokyo) 2022; 62: 307–12.","DOI":"10.2176\/jns-nmc.2022-0072"},{"key":"10.3238\/arztebl.m2025.0185_ref20","doi-asserted-by":"crossref","unstructured":"Suzuki J, Takaku A: Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288–99.","DOI":"10.1001\/archneur.1969.00480090076012"},{"key":"10.3238\/arztebl.m2025.0185_ref21","doi-asserted-by":"crossref","unstructured":"Mertens R, Acker G, Kersting K, et al.: Validation of the Berlin grading system for moyamoya angiopathy with the use of [(15)O]H(2)O PET. Neurosurg Rev 2022; 46: 25.","DOI":"10.1007\/s10143-022-01920-2"},{"key":"10.3238\/arztebl.m2025.0185_ref22","doi-asserted-by":"crossref","unstructured":"Yang H, Huang G, Li X, et al.: High-resolution magnetic resonance vessel wall imaging provides new insights into moyamoya disease. Front Neurosci 2024; 18: 1375645.","DOI":"10.3389\/fnins.2024.1375645"},{"key":"10.3238\/arztebl.m2025.0185_ref23","doi-asserted-by":"crossref","unstructured":"Li J, Jin M, Sun X, et al.: Imaging of moyamoya disease and moyamoya syndrome: Current status. J Comput Assist Tomogr 2019; 43.","DOI":"10.1097\/RCT.0000000000000834"},{"key":"10.3238\/arztebl.m2025.0185_ref24","doi-asserted-by":"crossref","unstructured":"Bersano A, Khan N, Fuentes B, et al.: European Stroke Organisation (ESO) Guidelines on moyamoya angiopathy endorsed by vascular European Reference Network (VASCERN). Eur Stroke J 2023; 8: 55–84.","DOI":"10.1177\/23969873221144089"},{"key":"10.3238\/arztebl.m2025.0185_ref25","doi-asserted-by":"crossref","unstructured":"Czabanka M, Pe\u00f1a-Tapia P, Schubert GA, et al.: Proposal for a new grading of moyamoya disease in adult patients. Cerebrovasc Dis 2011; 32: 41–50.","DOI":"10.1159\/000326077"},{"key":"10.3238\/arztebl.m2025.0185_ref26","doi-asserted-by":"crossref","unstructured":"Czabanka M, Boschi A, Acker G, et al.: Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery. Acta Neurochir (Wien) 2016; 158: 1895–900.","DOI":"10.1007\/s00701-016-2941-y"},{"key":"10.3238\/arztebl.m2025.0185_ref27","doi-asserted-by":"crossref","unstructured":"Teo M, Furtado S, Kaneko OF, et al.: Validation and application for the Berlin grading system of moyamoya disease in adult patients. Neurosurgery 2020; 86: 203–12.","DOI":"10.1093\/neuros\/nyz025"},{"key":"10.3238\/arztebl.m2025.0185_ref28","doi-asserted-by":"crossref","unstructured":"Kashiwazaki D, Akioka N, Kuwayama N, et al.: Berlin grading system can stratify the onset and predict perioperative complications in adult moyamoya disease. Neurosurgery 2017; 81: 986–91.","DOI":"10.1093\/neuros\/nyx140"},{"key":"10.3238\/arztebl.m2025.0185_ref29","doi-asserted-by":"crossref","unstructured":"Gross BA, Du R: The natural history of moyamoya in a North American adult cohort. J Clin Neurosci 2013; 20: 44–8.","DOI":"10.1016\/j.jocn.2012.08.002"},{"key":"10.3238\/arztebl.m2025.0185_ref30","doi-asserted-by":"crossref","unstructured":"Cho WS, Chung YS, Kim JE, et al.: The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg 2015; 122: 82–9.","DOI":"10.3171\/2014.9.JNS132281"},{"key":"10.3238\/arztebl.m2025.0185_ref31","doi-asserted-by":"crossref","unstructured":"Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y: incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005; 36: 2148–53.","DOI":"10.1161\/01.STR.0000182256.32489.99"},{"key":"10.3238\/arztebl.m2025.0185_ref32","doi-asserted-by":"crossref","unstructured":"Kuroda S, Yamamoto S, Funaki T, et al.: Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic moyamoya registry (AMORE). Stroke 2023; 54: 1494–504.","DOI":"10.1161\/STROKEAHA.122.041932"},{"key":"10.3238\/arztebl.m2025.0185_ref33","doi-asserted-by":"crossref","unstructured":"Kraemer M, Lee S-I, Ayzenberg I, et al.: Headache in Caucasian patients with moyamoya angiopathy—a systematic cohort study. Cephalalgia 2017; 37: 496–500.","DOI":"10.1177\/0333102416643516"},{"key":"10.3238\/arztebl.m2025.0185_ref34","doi-asserted-by":"crossref","unstructured":"Vajkoczy P (ed.): Surgical techniques in moyamoya vasculopathy. In: Surgical techniques in moyamoya vasculopathy. Stuttgart: Georg Thieme Verlag 2019.","DOI":"10.1055\/b-0039-172614"},{"key":"10.3238\/arztebl.m2025.0185_ref35","doi-asserted-by":"crossref","unstructured":"Acker G, Fekonja L, Vajkoczy P: Surgical management of moyamoya disease. Stroke 2018; 49: 476–82.","DOI":"10.1161\/STROKEAHA.117.018563"},{"key":"10.3238\/arztebl.m2025.0185_ref36","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, et al.: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: Results of the Japan adult moyamoya trial. Stroke 2014; 45: 1415–21."},{"key":"10.3238\/arztebl.m2025.0185_ref37","doi-asserted-by":"crossref","unstructured":"Li Q, Gao Y, Xin W, et al.: Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease. World Neurosurg 2019; 127: 354–61.","DOI":"10.1016\/j.wneu.2019.04.062"},{"key":"10.3238\/arztebl.m2025.0185_ref38","doi-asserted-by":"crossref","unstructured":"Nguyen VN, Motiwala M, Elarjani T, et al.: Direct, indirect, and combined extracranial-to-intracranial bypass for adult moyamoya disease: An updated systematic review and meta-analysis. Stroke 2022; 53: 3572–82.","DOI":"10.1161\/STROKEAHA.122.039584"},{"key":"10.3238\/arztebl.m2025.0185_ref39","doi-asserted-by":"crossref","unstructured":"Hackenberg A, Battilana B, Hebeisen M, Steinfeld R, Khan N: Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables. Eur J Paediatr Neurol 2021; 35: 130–6.","DOI":"10.1016\/j.ejpn.2021.10.007"},{"key":"10.3238\/arztebl.m2025.0185_ref40","doi-asserted-by":"crossref","unstructured":"Zheng J, Yu LB, Dai KF, Zhang Y, Wang R, Zhang D: Clinical features, surgical treatment, and long-term outcome of a multicenter cohort of pediatric moyamoya. Front Neurol 2019; 10: 14.","DOI":"10.3389\/fneur.2019.00014"},{"key":"10.3238\/arztebl.m2025.0185_ref41","doi-asserted-by":"crossref","unstructured":"Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S: A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med 2016; 21: 55–70.","DOI":"10.1007\/s12199-015-0498-7"},{"key":"10.3238\/arztebl.m2025.0185_ref42","doi-asserted-by":"crossref","unstructured":"Mineharu Y, Takenaka K, Yamakawa H, et al.: Inheritance pattern of familial moyamoya disease: Autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77: 1025–9.","DOI":"10.1136\/jnnp.2006.096040"},{"key":"10.3238\/arztebl.m2025.0185_ref43","doi-asserted-by":"crossref","unstructured":"Gonzalez NR, Amin-Hanjani S, Bang OY, et al.: Adult moyamoya disease and syndrome: Current perspectives and future directions: A scientific statement from the American Heart Association\/American Stroke Association. Stroke 2023; 54: e465–e79.","DOI":"10.1161\/STR.0000000000000443"},{"key":"10.3238\/arztebl.m2025.0185_ref44","doi-asserted-by":"crossref","unstructured":"Morito D, Nishikawa K, Hoseki J, et al.: Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep 2014; 4: 4442.","DOI":"10.1038\/srep04442"},{"key":"10.3238\/arztebl.m2025.0185_ref45","doi-asserted-by":"crossref","unstructured":"Thery F, Martina L, Asselman C, et al.: Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. Nat Commun 2021; 12: 5772.","DOI":"10.1038\/s41467-021-26061-w"},{"key":"10.3238\/arztebl.m2025.0185_ref46","doi-asserted-by":"crossref","unstructured":"Lucia K, Acker G, Mrosk F, Beyaztas D, Vajkoczy P: Longitudinal angiographic characterization of the efficacy of combined cerebral revascularization using minimally invasive encephalodurosynangiosis in patients with moyamoya angiopathy. Neurosurg Rev 2022; 45: 3689–98.","DOI":"10.1007\/s10143-022-01862-9"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:53:31Z","timestamp":1765781611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2025.0185","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}